Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study Meeting Abstract

  

Authors:	Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; Gorsky, M.; Bromberg, J.; Drullinsky, P.; Lake, D.; Wong, S.; DeFusco, P.; Lamparella, N.; Gupta, R.; Tabassum, T.; Boyle, L. A.; Arumov, A.; Traina, T. A.
Abstract Title:	Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
Meeting Title:	2021 San Antonio Breast Cancer Symposium
Journal Title:	Cancer Research
Volume:	82
Issue:	4 Suppl.
Meeting Dates:	2021 Dec 7-10
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2022-02-15
Language:	English
ACCESSION:	WOS:000772647600243
DOI:	10.1158/1538-7445.Sabcs21-p1-14-03
PROVIDER:	wos
Notes:	Meeting Abstract: P1-14-03 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/199615